The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of early trials in molecularly-characterized patients (pts) with head and neck cancer (HNC).
 
Neus Baste
Consulting or Advisory Role - MSD Oncology
 
Rodrigo Dienstmann
Consulting or Advisory Role - Astellas Pharma; Roche/Genentech
Research Funding - Merck
 
Irene Brana
Consulting or Advisory Role - Merck Serono
 
Cristina Viaplana
No Relationships to Disclose
 
Jose Jimenez
No Relationships to Disclose
 
Fiorella Ruiz-Pace
No Relationships to Disclose
 
Coro Bescos
No Relationships to Disclose
 
Juan Lorente
No Relationships to Disclose
 
Jordi Giralt
No Relationships to Disclose
 
Margarita Alberola
No Relationships to Disclose
 
Paolo Nuciforo
No Relationships to Disclose
 
Ana Vivancos
Consulting or Advisory Role - Merck Serono
 
Jose Maria Del Campo
Speakers' Bureau - Boehringer Ingelheim; MSD Oncology; PharmaMar; Roche
 
Josep Tabernero
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Celgene; Chugai Pharma; Lilly; Merck Serono; MSD; Novartis; Pfizer; Roche; Sanofi; Symphony Evolution; Taiho Pharmaceutical; Takeda
 
Enriqueta Felip
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; MSD; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Novartis
 
Jordi Rodon
No Relationships to Disclose